Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Muth, K; Yu, E; Alston, B; Ellenberg, JH
   The closeout process for a clinical trial terminated early for lagging enrollment and inadequate follow-up
   CONTROLLED CLINICAL TRIALS
   
   K. Muth et al., "The closeout process for a clinical trial terminated early for lagging enrollment and inadequate follow-up", CONTR CL TR, 22(1), 2001, pp. 49-55
2. Alston, B; Ellenberg, JH; Standiford, HC; Muth, K; Martinez, A; Greaves, W; Kumi, J
   A multicenter, randomized, controlled trial of three preparations of low-dose oral alpha-interferon in HIV-infected patients with CD4(+) counts between 50 and 350 cells/mm(3)
   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
   
   B. Alston et al., "A multicenter, randomized, controlled trial of three preparations of low-dose oral alpha-interferon in HIV-infected patients with CD4(+) counts between 50 and 350 cells/mm(3)", J ACQ IMM D, 22(4), 1999, pp. 348-357
3. Hafner, R; Inderlied, CB; Peterson, DM; Wright, DJ; Standiford, HC; Drusano, G; Muth, K
   Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection
   JOURNAL OF INFECTIOUS DISEASES
   
   R. Hafner et al., "Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection", J INFEC DIS, 180(2), 1999, pp. 438-447
4. MUTH K; BRUYNS R; THOREY IS; VONMELCHNER H
   DISRUPTION OF GENES REGULATED DURING HEMATOPOIETIC DIFFERENTIATION OFMOUSE EMBRYONIC STEM-CELLS
   Developmental dynamics
   
   K. Muth et al., "DISRUPTION OF GENES REGULATED DURING HEMATOPOIETIC DIFFERENTIATION OFMOUSE EMBRYONIC STEM-CELLS", Developmental dynamics, 212(2), 1998, pp. 277-283
5. THOREY IS; MUTH K; RUSS AP; OTTE J; REFFELMANN A; VONMELCHNER H
   SELECTIVE DISRUPTION OF GENES TRANSIENTLY INDUCED IN DIFFERENTIATING MOUSE EMBRYONIC STEM-CELLS BY USING GENE TRAP MUTAGENESIS AND SITE-SPECIFIC RECOMBINATION
   Molecular and cellular biology
   
   I.S. Thorey et al., "SELECTIVE DISRUPTION OF GENES TRANSIENTLY INDUCED IN DIFFERENTIATING MOUSE EMBRYONIC STEM-CELLS BY USING GENE TRAP MUTAGENESIS AND SITE-SPECIFIC RECOMBINATION", Molecular and cellular biology, 18(5), 1998, pp. 3081-3088
6. THOREY IS; MUTH K; RUSS AP; OTTE J; REFFELMANN A; VONMELCHNER H
   SELECTIVE DISRUPTION OF GENES TRANSIENTLY INDUCED IN DIFFERENTIATING MOUSE EMBRYONIC STEM-CELLS BY USING GENE TRAP MUTAGENESIS AND SITE-SPECIFIC RECOMBINATION (VOL 18, PG 3081, 1998)
   Molecular and cellular biology
   
   I.S. Thorey et al., "SELECTIVE DISRUPTION OF GENES TRANSIENTLY INDUCED IN DIFFERENTIATING MOUSE EMBRYONIC STEM-CELLS BY USING GENE TRAP MUTAGENESIS AND SITE-SPECIFIC RECOMBINATION (VOL 18, PG 3081, 1998)", Molecular and cellular biology, 18(10), 1998, pp. 6164-6164
7. HAFNER R; COHN JA; WRIGHT DJ; DUNLAP NE; EGORIN MJ; ENAMA ME; MUTH K; PELOQUIN CA; MOR N; HEIFETS LB; DUNLAP N; PHILLIPS P; CAMPO R; JAMES P; SENSION M; BOURIE M; WITT M; KRUGER S; MUSHATT D; GREENSPAN D
   EARLY BACTERICIDAL ACTIVITY OF ISONIAZID IN PULMONARY TUBERCULOSIS - OPTIMIZATION OF METHODOLOGY
   American journal of respiratory and critical care medicine
   
   R. Hafner et al., "EARLY BACTERICIDAL ACTIVITY OF ISONIAZID IN PULMONARY TUBERCULOSIS - OPTIMIZATION OF METHODOLOGY", American journal of respiratory and critical care medicine, 156(3), 1997, pp. 918-923
8. GORDIN FM; NELSON ET; MATTS JP; COHN DL; ERNST J; BENATOR D; BESCH CL; CRANE LR; SAMPSON JH; BRAGG PS; ELSADR W; KOYANDE D; POLLARD C; TELZAK E; STANDRIDGE B; ZAHNOW K; WALDMANN C; WALKER J; PABLOVICH S; KISSINGER P; DEISINGER G; FLEMING D; NEER C; MERKERING TM; MILLER GB; HALES D; ROYBAL A; SARAVOLATZ L; FABER L; KUMI J; SIVAPALAN V; GUITY C; TORRES RA; DOWLING C; ZBIKOWSKI V; KRUPA R; SULLIVAN R; LUSKINHAWK R; TAYLOR VM; ALHADDADIN D; MOAVEN N; BROWN LS; JOHN SL; ELLISON J; MUTH K; MIATICO MG; DEYTON B; GROOM C
   THE IMPACT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ON DRUG-RESISTANT TUBERCULOSIS
   American journal of respiratory and critical care medicine
   
   F.M. Gordin et al., "THE IMPACT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ON DRUG-RESISTANT TUBERCULOSIS", American journal of respiratory and critical care medicine, 154(5), 1996, pp. 1478-1483
9. ROSSI S; SCHROEDER T; MUTH K; HANTO D; MUNDA R; HARIHARAN S; FIRST MR; RYCKMAN F; BALISTRERI W
   SERIAL MONITORING OF SOLUBLE INTERLEUKIN-2 RECEPTOR AS A RAPID MARKEROF CYTOMEGALOVIRUS-INFECTION AND RESPONSE TO ANTIVIRAL THERAPY
   Clinical transplantation
   
   S. Rossi et al., "SERIAL MONITORING OF SOLUBLE INTERLEUKIN-2 RECEPTOR AS A RAPID MARKEROF CYTOMEGALOVIRUS-INFECTION AND RESPONSE TO ANTIVIRAL THERAPY", Clinical transplantation, 10(1), 1996, pp. 45-50
10. WEBSTER CT; GORDIN FM; MATTS JP; KORVICK JA; MILLER C; MUTH K; BROWN LS; BESCH CL; KUMI JO; SALVESON C; BINCSIK A; IRVIN K; MAIATICO G
    2-STAGE TUBERCULIN SKIN TESTING IN INDIVIDUALS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    American journal of respiratory and critical care medicine
    
    C.T. Webster et al., "2-STAGE TUBERCULIN SKIN TESTING IN INDIVIDUALS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION", American journal of respiratory and critical care medicine, 151(3), 1995, pp. 805-808
11. MUTH K
    LIFE IN THE REAL-WORLD
    CMAJ. Canadian Medical Association journal
    
    K. Muth, "LIFE IN THE REAL-WORLD", CMAJ. Canadian Medical Association journal, 151(8), 1994, pp. 1171-1172
12. ABRAMS DI; GOLDMAN AI; LAUNER C; KORVICK JA; NEATON JD; CRANE LR; GRODESKY M; WAKEFIELD S; MUTH K; KORNEGAY S; COHN DL; HARRIS A; LUSKINHAWK R; MARKOWITZ N; SAMPSON JH; THOMPSON M; DEYTON L
    A COMPARATIVE TRIAL OF DIDANOSINE OR ZALCITABINE AFTER TREATMENT WITHZIDOVUDINE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    The New England journal of medicine
    
    D.I. Abrams et al., "A COMPARATIVE TRIAL OF DIDANOSINE OR ZALCITABINE AFTER TREATMENT WITHZIDOVUDINE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION", The New England journal of medicine, 330(10), 1994, pp. 657-662
13. JACOBSON MA; BESCH CL; CHILD C; HAFNER R; MATTS JP; MUTH K; WENTWORTH DN; NEATON JD; ABRAMS D; RIMLAND D; PEREZ G; GRANT IH; SARAVOLATZ LD; BROWN LS; DEYTON L
    PRIMARY PROPHYLAXIS WITH PYRIMETHAMINE FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - RESULTS OF A RANDOMIZED TRIAL
    The Journal of infectious diseases
    
    M.A. Jacobson et al., "PRIMARY PROPHYLAXIS WITH PYRIMETHAMINE FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - RESULTS OF A RANDOMIZED TRIAL", The Journal of infectious diseases, 169(2), 1994, pp. 384-394
14. ERB KJ; HOLTSCHKE T; MUTH K; HORAK I; SCHIMPL A
    T-CELL SUBSET DISTRIBUTION AND B-CELL HYPERREACTIVITY IN MICE EXPRESSING INTERLEUKIN-4 UNDER THE CONTROL OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I REGULATORY SEQUENCES
    European Journal of Immunology
    
    K.J. Erb et al., "T-CELL SUBSET DISTRIBUTION AND B-CELL HYPERREACTIVITY IN MICE EXPRESSING INTERLEUKIN-4 UNDER THE CONTROL OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I REGULATORY SEQUENCES", European Journal of Immunology, 24(5), 1994, pp. 1143-1147
15. GORDIN F; THOMPSON C; MATTS J; MUTH K; KORVICK J; DEYTON L
    THE UTILITY OF 2-STAGE TUBERCULIN (PPD) SKIN TESTING IN INDIVIDUALS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
    The American review of respiratory disease
    
    F. Gordin et al., "THE UTILITY OF 2-STAGE TUBERCULIN (PPD) SKIN TESTING IN INDIVIDUALS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION", The American review of respiratory disease, 147(4), 1993, pp. 487-487